je.st
news
Tag: fda approval
Milliken ClearTint® Liquid Polymeric Colorants Win FDA Approval for Clarified PP and ...
2014-05-08 06:00:00| Industrial Newsroom - All News for Today
Spartanburg, S.C. – Milliken & Company today announced that its ClearTint® polymeric colorants have received approval from the U.S. Food and Drug Administration (FDA) for use in food contact applications. All five ClearTint primaries, the basis for all the company's ClearTint colors, have been approved under the FDA's Food Contact Notification program. Milliken's proactive efforts to secure agency approval, undertaken on behalf of customers, will benefit manufacturers of food containers ...This story is related to the following:Food Processing and PreparationSearch for suppliers of: Food Additives
FDA weighs over-the-counter approval of Singulair
2014-04-30 19:36:17| Biotech - Topix.net
Federal health regulators are weighing the risks of permitting Merck to sell its prescription respiratory pill, Singulair, as an over-the-counter medicine for allergies.
Tags: approval
fda
weighs
singulair
Cochlear Receives FDA Approval of the Aqua+ Accessory - the Cochlear(TM) Nucleus® ...
2014-04-21 06:00:00| Industrial Newsroom - All News for Today
CENTENNIAL, Colo. - Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced that the US Food and Drug Administration (FDA) has approved the Aqua+ accessory, the only waterproof behind-the-ear solution for cochlear implant recipients on the market today. The Aqua+ is a form-fitting, easy-to-use, versatile accessory that allows Cochlear™ Nucleus® 5 and Nucleus 6 Implant recipients(2) to swim underwater for up to two hours. <br /> <br /> The new Aqua+ ...This story is related to the following:Health, Medical and Dental Supplies and EquipmentSearch for suppliers of: Audio Signal Processors |
Tags: approval
receives
accessory
aqua
Merck Receives FDA Approval for ISENTRESS (raltegravir) for Pediatric Oral Suspension
2014-01-08 14:30:00| Merck.com - Product News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) recently approved ISENTRESS for oral suspension, a new pediatric formulation of Mercks integrase inhibitor. With this approval, ISENTRESS is now indicated in combination with other antiretroviral (ARV) agents for the treatment of HIV-1 infection in patients four weeks of age and older. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558orSarra Herzog, 908-423-6154orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: approval
oral
receives
suspension
Teva's Generic Version of Xeloda Gains FDA Approval For Metastatic Colorectal And Breast Cancers
2013-09-17 08:07:34| Biotech - Topix.net
The FDA granted approval to a generic version of Xeloda, produced by Teva Pharmaceutical, for the treatment of metastatic colorectal and breast cancers.
Tags: version
approval
generic
gains
Sites : [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] next »